Print | Save or Share

FDA Sends Wyeth Warning Letter Over Effexor Ad

ROCKVILLE, Md., Dec. 14, 2007-The FDA today posted on its website a warning letter sent to Wyeth Pharmaceuticals Inc. over a professional journal ad for depression drug Effexor XR. The letter and promotional material is attached.

Latest Pharma Industry News...

Pharma Industry News Archive

2010: Jan | Feb |
2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec |
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec |

More News Resources

Sign In or Register

Forgot password?

Latest FDA Drug Alerts

Get alerts delivered by email

Tysabri (Natalizumab): Update of Healthcare Professional Information February 5, 2010
FDA notified healthcare professionals and patients that the risk of developing progressive multifocal leukoencephalopathy (PML) increases with the number of ...
Zyprexa (olanzapine): Use in Adolescents January 29, 2010
Lilly and FDA notified healthcare professionals of changes to the Prescribing Information for Zyprexa related to its indication for use in adolescents (ages ...
Videx/Videx EC (didanosine): Labeling Revision - Risk of Non-Cirrhotic Portal Hypertension January 29, 2010
FDA notified healthcare professionals and patients about a rare, but serious, complication in the liver known as non-cirrhotic portal hypertension in patients ...

Get Updates by Email

Email me:

Latest Drug Information Updates

Victoza
Victoza (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Ampyra
Ampyra (dalfampridine) is an oral potassium channel blocker indicated to improve walking ability in people with multiple sclerosis.

Actemra
Actemra (tocilizumab) is a humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody for the treatment of moderate to severe rheumatoid arthritis in adults.

Wilate
Wilate is a von Willebrand Factor/Coagulation Factor VIII Complex (Human) indicated for the treatment of spontaneous and trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD).

Zyprexa Relprevv
Zyprexa Relprevv (olanzapine) is a long-acting atypical antipsychotic for intramuscular injection indicated for the treatment of schizophrenia.

Zegerid OTC
Zegerid OTC (omeprazole and sodium bicarbonate) is an over-the-counter version of the prescription heartburn medicine Zegerid.

Drugs in the Pipeline

Support

About Drugs.com

Your Privacy

Drugs.com provides free, accurate and independent advice on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Data sources include Micromedex™ [Updated 2 February 2010], Cerner Multum™ [Updated 22 January 2010], Wolters Kluwer™ [Updated 3 February 2010] and others. To view content sources and attributions, refer to our editorial policy.

Copyright © 2000-2010 Drugs.com. All rights reserved.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

(web2)